Literature DB >> 34028841

Macrophage-fibroblast circuits in the spleen.

Alicia Bellomo1, Rebecca Gentek2, Rachel Golub3,4, Marc Bajénoff5.   

Abstract

Macrophages are an integral part of all organs in the body, where they contribute to immune surveillance, protection, and tissue-specific homeostatic functions. This is facilitated by so-called niches composed of macrophages and their surrounding stroma. These niches structurally anchor macrophages and provide them with survival factors and tissue-specific signals that imprint their functional identity. In turn, macrophages ensure appropriate functioning of the niches they reside in. Macrophages thus form reciprocal, mutually beneficial circuits with their cellular niches. In this review, we explore how this concept applies to the spleen, a large secondary lymphoid organ whose primary functions are to filter the blood and regulate immunity. We first outline the splenic micro-anatomy, the different populations of splenic fibroblasts and macrophages and their respective contribution to protection of and key physiological processes occurring in the spleen. We then discuss firmly established and potential cellular circuits formed by splenic macrophages and fibroblasts, with an emphasis on the molecular cues underlying their crosstalk and their relevance to splenic functionality. Lastly, we conclude by considering how these macrophage-fibroblast circuits might be impaired by aging, and how understanding these changes might help identify novel therapeutic avenues with the potential of restoring splenic functions in the elderly.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Keywords:  macrophage; niche; spleen; stromal cell

Year:  2021        PMID: 34028841     DOI: 10.1111/imr.12979

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  2 in total

1.  Plasmodium vivax Protein PvTRAg23 Triggers Spleen Fibroblasts for Inflammatory Profile and Reduces Type I Collagen Secretion via NF-κBp65 Pathway.

Authors:  Hangye Zhang; Feihu Shen; Jiali Yu; Jieyun Ge; Yifan Sun; Haitian Fu; Yang Cheng
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

2.  Blocking the A2B adenosine receptor alleviates myocardial damage by inhibiting spleen-derived MDSC mobilisation after acute myocardial infarction.

Authors:  Zongying Yu; Yang Ling; Qiancheng Xu; Yuhan Cao; Shengxing Tang; Cong Fu
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.